Brind.
  1. The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.
  2. FDA cleared NeuroOne Medical Technologies' OneRF system for facial pain treatment.

NeuroOne Medical Technologies filed a submission and received a patent allowance for its OneRF Trigeminal Nerve Ablation System.

3 reports, 1 independent Updated Aug 14
Gone quiet
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

NeuroOne Medical Technologies filed a submission and received a patent allowance for its OneRF Trigeminal Nerve Ablation System.

Who's involved

What this event is mainly about
FDA

Keep exploring

Part of

FDA cleared NeuroOne Medical Technologies' OneRF system for facial pain treatment. All 1 developments

Within The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireNeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At
  • GlobeNewswireNeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn.,
1 more outlet ran the same wire story